Jin Medical International
ZJYL
18 hedge funds and large institutions have $2.98M invested in Jin Medical International in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 1
200% more funds holding
Funds holding: 6 → 18 (+12)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
65% more capital invested
Capital invested by funds: $1.81M → $2.98M (+$1.17M)
0.4% more ownership
Funds ownership: 0.09% → 0.5% (+0.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$1.04M |
| 3 |
Millennium Management
New York
|
+$559K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$529K |
| 5 |
Jane Street
New York
|
+$257K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$78.4K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.73K |
ZJYL Hedge Fund Activity: Q1 2024 in Review
18 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q1 2024, worth a combined $2.98M — up 65% from $1.81M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ZJYL positions and 1 closed out — a net gain of 12 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $1.4M. The largest seller was UBS Group, cutting an estimated $78.4K.
- 18 institutional investors held Jin Medical International (ZJYL) as of Q1 2024, up from 6 in Q4 2023.
- Funds reported $2.98M of Jin Medical International stock for Q1 2024, up 65% quarter-over-quarter.
- 13 funds opened new Jin Medical International positions in Q1 2024 and 1 closed out, a net change of +12 holders.
- The largest Jin Medical International buyer in Q1 2024 was Marshall Wace, an estimated $1.4M added.
- The largest Jin Medical International seller in Q1 2024 was UBS Group, an estimated $78.4K sold.
Based on aggregated 13F filings for Q1 2024.